International standards and international reference preparations: amphotericin B, vancomycin, capreomycin, cefalotin, demethylchlortetracycline, gentamycin, gramicidin S, kanamycin and kanamycin B, lincomycin, lymecycline, methacycline, paromomycin, rifamycin SV, ristocetin and ristocetin B, spiramycin, and triacetyloleandomycin.
Each of the preparations described here was obtained and evaluated at the request of a WHO Expert Committee on Biological Standardization. Unless otherwise stated, a standard procedure was used to distribute the material into individual ampoules. The procedure was as follows. Upon receipt by the National Institute for Medical Research (NIMR), London, materials were stored temporarily in the dark at a temperature of -10 degrees C or lower, and protected from moisture. At a convenient time they were brought back to room temperature, mixed, and distributed into individual neutral glass ampoules so that each ampoule contained 50-100 mg of powder. If it was known that the material was light-sensitive non-actinic glass ampoules were used. After exhaustive drying in vacuum over phosphorus(V) oxide, the ampoules were either constricted (up to 1963) or fitted with capillary leak plugs, dried for a further period under the same conditions, filled with dry nitrogen, and sealed by fusion of the glass. The total drying period varied from 8 to 38 days according to the nature of the material. After they had been tested for leaks, the ampoules were stored in the dark at -20 degrees C.
D000666:Amphotericin B / Q000592:standards; D000900:Anti-Bacterial Agents / Q000592:standards*; D000995:Antitubercular Agents / Q000592:standards*; D002207:Capreomycin / Q000592:standards; D002512:Cephalothin / Q000592:standards; D003707:Demeclocycline / Q000592:standards; D005839:Gentamicins / Q000592:standards; D007391:International Cooperation; D007612:Kanamycin / Q000592:standards; D007933:Leucomycins / Q000592:standards; D008034:Lincomycin / Q000592:standards; D008194:Lymecycline / Q000592:standards; D008690:Methacycline / Q000592:standards; D010303:Paromomycin / Q000592:standards; D012294:Rifamycins / Q000592:standards; D012310:Ristocetin / Q000592:standards; D014217:Troleandomycin / Q000592:standards; D014449:Tyrothricin / Q000592:standards; D014640:Vancomycin / Q000592:standards; D014944:World Health Organization
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D005839:Gentamicins; D007933:Leucomycins; D012294:Rifamycins; D002207:Capreomycin; D012310:Ristocetin; D014449:Tyrothricin; D007612:Kanamycin; D003707:Demeclocycline; D010303:Paromomycin; D014640:Vancomycin; D008194:Lymecycline; D000666:Amphotericin B; D008034:Lincomycin; D014217:Troleandomycin; D008690:Methacycline; D002512:Cephalothin